... with MultipleSclerosis Seok Jae Kang, MD a ; Joo-Hark Yi, MD b ; Hyun-Seok Hong, MD b ; Si-Hyung Jang, MD c ; Moon-Hyang Park, MD c ; Ho-Jung Kim, MD b ; Kyu-Yong Lee, MD a ; Young-Joo Lee, MD a ; ...
... 다발성 경화증(Multiplesclerosis) 치료의 최신 동향 민경우 Page 9 / 12 확증하기 위해서는 더 자세한 연구가 필요할 것이다. 6. 결론 이상에서 살펴본 바대로, 다발성 경화증은 자가면역질환이라는 것이 잘 알려져 있지만 어떤 이유로 면역세포가 신경수초를 공격하는지 정확한 기작이 밝혀져 있지 않다. 그런 이유로 현재까지 개발된 치료제들은 면역세포가 ...
... However, the outcomes of RRMS patients were more im- pressive. In the first double-blind, placebo-controlled, random- ized trial, both the frequency and severity of relapses were re- duced and MRI results improved. MRI ...
... C병원에서 Multiplesclerosis Dx 받고 계속적 으로 치료받아 오시던 중 본원 입원 6일전 사지 의 소력감 및 저림감이 5번째로 재발하여 C병 원 입원하여 고용량 스테로이드 치료 받으신 후 혈전교환술 권유 받았으나 거절하고 보호자 및 환자가 본원의 한방치료 원하여 ...
... the MultipleSclerosis Impact Scale (MSIS-29) and the MultipleSclerosis International Quality of Life (MusiQoL) questionnaires as two MS-specific instru- ments, 6,7 since general HRQoL ...
... Conclusions zzMost MS patients seeking ED care suffer from acute nonneurological problems. The MS patients presenting to the ED tended to be underinsured, had high levels of disability, and were undertreated with ...
... Multiplesclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system that leads to neurological disability. The diagnosis of MS relies on the MRI criteria, which can ...
... 1229-6414 Multiplesclerosis is an autoimmune demyeli- nating disorder of the nervous ...tiple sclerosis with lesions affecting the pon- tomesencephalic junction, the rostral medulla, the caudal ...
... 2019 Multiplesclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are immune-mediated demyelinating disease of the central nervous systems characterized by immunological and pathological fea- ...
... for MultipleSclerosis INTRODUCTION Clinically isolated syndrome (CIS) describes the first clinical neurological episode when a patient has symptoms and signs suggestive of multiplesclerosis ...
... Here we report a case of pediatric multiplesclerosis treated with interferon β-1b. Interferon beta is widely used in adult patients with multiplesclerosis (MS). However, its effects and ...
... in MultipleSclerosis‑related Trigeminal Neuropathy A 31‑year‑old man presented with ten days of numbness in his left tongue and lips as if he just had dental ...
... 10) Fassas A, Kimiskidis VK. Stem cell transplantation for multiplesclerosis: What is the evidence? Blood Reviews 2003;17:233-40. 11) Hess AD, Horwitz LR, Laulis MK, Fuchs E. Cyclos- porine-induced ...
... Multiplesclerosis patients with refractory urinary symptoms after treatment with behavioral therapy and medications still have treatment options. Prior to starting treatments, baseline symptoms should be ...
... Conflicts of Interest This study was supported by the grant from Teva-Handok. Hyun has received a grant from the National Research Foundation of Korea. Kim SH has lectured, consulted, and received honoraria from Bay- er ...
... 3. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiplesclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302. 4. Vukusic S, ...
... Conclusions zzPPUN is an infrequent, ocular manifestation noted during an acute attack of MS, and was observed in 5% of the present cases. Brainstem lesions in these cases primarily involved the pontine tegmentum and the ...
... Purpose: Multiplesclerosis (MS) in Asians is characterized by frequent involvement of the spinal cord and optic nerve and low prevalence rates, but even the most fundamental epidemiologic findings and ...
... MultipleSclerosis in Sri Lanka JCN McDonald 2010 MRI criteria use magnetic resonance im- aging in multiplesclerosis (MAGNIMS) dissemination in space (DIS) criteria to identify ...